Alexandria Venture
41
38M
36
1.52
1
0.12
15
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. Alexandria Venture appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the San Francisco.
The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This Alexandria Venture works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity.
This organization was formed by Joel Marcus.
Among the most popular portfolio startups of the fund, we may highlight Relay Therapeutics, Vividion Therapeutics, Synthego. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Therapeutics.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Alexandria Venture, startups are often financed by Flagship Pioneering, ARCH Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Pfizer Venture Investments, Polaris Partners. In the next rounds fund is usually obtained by Polaris Partners, iSELECT FUND, Lundbeckfonden Ventures.
Investments analytics
Analytics
- Total investments
- 41
- Lead investments
- 1
- Exits
- 15
- Rounds per year
- 1.52
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (38)
- Health Care (24)
- Therapeutics (17)
- Medical (10)
- Pharmaceutical (7) Show 25 more
- Investments by region
-
- United States (40)
- Canada (1)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 50M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 2.47
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Anipen | 01 Apr 2018 | Internet, Video, Digital Entertainment | Early Stage Venture | 5M | Kyonggi-do, Seongnam, South Korea |
Radiant Biotherapeutics | 25 Apr 2023 | Biotechnology, Therapeutics | Seed | 8M | Ontario, Toronto, Canada |
Vtesse | 25 Jul 2016 | Biotechnology, Health Care, Consumer Research | Early Stage Venture | 17M | United States, Maryland |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.